A carregar...

POSSIBILITIES OF A COMBINATION OF DOCETAXEL WITH ANDROGEN DEPRIVATION IN INITIAL THERAPY OF HORMONESENSITIVE PROSTATE CANCER

Androgen deprivation therapy (ADT) is used in the treatment of prostate cancer metastatic cancer (PC) since the first description of its hormone dependence in 1941. After receiving the results of a TAX 327 study in 2004, the drug from the taxanes - docetaxel became the main cytostatic agent in the t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: A. A. GRITSKEVICH, S. V. MISHUGIN, I. G. RUSAKOV
Formato: Artigo
Idioma:Russo
Publicado em: Remedium Group LLC 2017-06-01
Colecção:Медицинский совет
Assuntos:
Acesso em linha:https://www.med-sovet.pro/jour/article/view/1892
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!